Reduced frequency of a CD14+ CD16+ monocyte subset with high toll-like receptor 4 expression in cord blood compared to adult blood contributes to lipopolysaccharide hyporesponsiveness in newborns

Clinical and Vaccine Immunology

Volumn 20, Issue 7, 2013, Pages 962-971

  Pedraza Sańchez, Sigifredo ^a,c   Hise, Amy G ^a   Ramachandra, Lakshmi ^a,d   Arechavaleta Velasco, Fabian ^b   King, Christopher L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; INTERLEUKIN 1ALPHA; LIPOARABINOMANNAN; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ETHNIC GROUP; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; KENYA; MONOCYTE; NEWBORN; NORTH AMERICA; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

ADULT; ANTIGENS, CD14; ESCHERICHIA COLI; FEMALE; FETAL BLOOD; GENE EXPRESSION; GPI-LINKED PROTEINS; HUMANS; INFANT, NEWBORN; LIPOPOLYSACCHARIDES; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; PREGNANCY; RECEPTORS, IGG; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880500884     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00609-12     Document Type: Article

References (65)

1. Velilla PA, Rugeles MT, Chougnet CA. 2006. Defective antigen-presenting cell function in human neonates. Clin. Immunol. 121:251-259. (Pubitemid 44768008)
2. Goriely S, Vincart B, Stordeur P, Vekemans J, Willems F, Goldman M, De Wit D. 2001. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J. Immunol. 166:2141-2146. (Pubitemid 32114705)
3. Hebra A, Kramer R, Johnson JT, Wagner CL, Eicher DJ, Cook J. 1999. Detection of intracellular tumor necrosis factor alpha in stimulated fetal cells. J. Surg. Res. 82:300-304. (Pubitemid 29394137)
4. Hodge S, Hodge G, Flower R, Han P. 2001. Cord blood leucocyte expression of functionally significant molecules involved in the regulation of cellular immunity. Scand. J. Immunol. 53:72-78. (Pubitemid 32113359)
5. Krampera M, Tavecchia L, Benedetti F, Nadali G, Pizzolo G. 2000. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes. Haematologica 85:675-679. (Pubitemid 30617100)
6. Karlsson H, Hessle C, Rudin A. 2002. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect. Immun. 70:6688-6696. (Pubitemid 35387899)
7. Berner R, Welter P, Brandis M. 2002. Cytokine expression of cord and adult blood mononuclear cells in response to Streptococcus agalactiae. Pediatr. Res. 51:304-309. (Pubitemid 34174965)
8. Scott ME, Kubin M, Kohl S. 1997. High level interleukin-12 production, but diminished interferon-gamma production, by cord blood mononuclear cells. Pediatr. Res. 41:547-553. (Pubitemid 27147872)
9. Takeda K, Akira S. 2003. Toll receptors and pathogen resistance. Cell. Microbiol. 5:143-153. (Pubitemid 36348031)
10. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-3752. (Pubitemid 29314747)
11. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevik T, Ingalls RR, Radolf JD, Golenbock DT. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419-33425. (Pubitemid 129511647)
12. Means TK, Lien E, Yoshimura A, Wang S, Golenbock DT, Fenton MJ. 1999. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 163:6748-6755.
13. Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376. (Pubitemid 37174535)
14. Lu YC, Yeh WC, Ohashi PS. 2008. LPS/TLR4 signal transduction pathway. Cytokine 42:145-151.
15. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI. 2002. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3:354-359. (Pubitemid 34308623)
16. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, Espevik T, Ziegler-Heitbrock L. 2002. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 168:3536-3542. (Pubitemid 34250422)
17. Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B, Puel A, Biswas SK, Moshous D, Picard C, Jais JP, D'Cruz D, Casanova JL, Trouillet C, Geissmann F. 2010. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33:375-386.
18. Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler-Heitbrock HW. 1996. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 87:373-377. (Pubitemid 26011852)
19. Serbina NV, Cherny M, Shi C, Bleau SA, Collins NH, Young JW, Pamer EG. 2009. Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia. J. Immunol. 183:2678-2687.
20. Ziegler-Heitbrock L. 2007. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J. Leukoc. Biol. 81:584-592. (Pubitemid 46393535)
21. Kawanaka N, Yamamura M, Aita T, Morita Y, Okamoto A, Kawashima M, Iwahashi M, Ueno A, Ohmoto Y, Makino H. 2002. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 46:2578-2586. (Pubitemid 36118920)
22. Koch S, Kucharzik T, Heidemann J, Nusrat A, Luegering A. 2010. Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease. Clin. Exp. Immunol. 161:332-341.
23. Merino A, Buendia P, Martin-Malo A, Aljama P, Ramirez R, Carracedo J. 2011. Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. J. Immunol. 186:1809-1815.
24. Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M, Ziegler-Heitbrock HW. 1993. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82:3170-3176. (Pubitemid 23334947)
25. Allen JB, Wong HL, Guyre PM, Simon GL, Wahl SM. 1991. Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta. J. Clin. Invest. 87:1773-1779.
26. Ancuta P, Kunstman KJ, Autissier P, Zaman T, Stone D, Wolinsky SM, Gabuzda D. 2006. CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology 344:267-276. (Pubitemid 43049614)
27. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS. 1997. Unique monocyte subset in patients with AIDS dementia. Lancet 349:692-695. (Pubitemid 27107748)
28. Chimma P, Roussilhon C, Sratongno P, Ruangveerayuth R, Pattanapanyasat K, Perignon JL, Roberts DJ, Druilhe P. 2009. A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria. PLoS Pathog. 5:e1000631. doi:10.1371/journal. ppat.1000631.
29. Ogonda LA, Orago AS, Otieno MF, Adhiambo C, Otieno W, Stoute JA. 2010. The levels of CD16/Fc gamma receptor IIIA on CD14+ CD16+ monocytes are higher in children with severe Plasmodium falciparum anemia than in children with cerebral or uncomplicated malaria. Infect. Immun. 78:2173-2181.
30. Forster-Waldl E, Sadeghi K, Tamandl D, Gerhold B, Hallwirth U, Rohrmeister K, Hayde M, Prusa AR, Herkner K, Boltz-Nitulescu G, Pollak A, Spittler A. 2005. Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr. Res. 58:121-124. (Pubitemid 40967441)
31. Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, Wessels MR. 2004. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J. Immunol. 173:4627-4634. (Pubitemid 39280696)
32. Yan SR, Qing G, Byers DM, Stadnyk AW, Al-Hertani W, Bortolussi R. 2004. Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect. Immun. 72:1223-1229. (Pubitemid 38263739)
33. Qing G, Howlett S, Bortolussi R. 1996. Lipopolysaccharide binding proteins on polymorphonuclear leukocytes: comparison of adult and neonatal cells. Infect. Immun. 64:4638-4642. (Pubitemid 26357070)
34. Ridings J, Weedon H, Ioannou C, Flego L, Macardle PJ, Zola H. 1996. Purification of cord blood lymphocytes. J. Immunol. Methods 195:43-48. (Pubitemid 26292686)
35. Delude RL, Yoshimura A, Ingalls RR, Golenbock DT. 1998. Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-alpha, signal transduction. J. Immunol. 161:3001-3009. (Pubitemid 28425725)
36. Malhotra I, Mungai P, Muchiri E, Kwiek JJ, Meshnick SR, King CL. 2006. Umbilical cord-blood infections with Plasmodium falciparum malaria are acquired antenatally in Kenya. J. Infect. Dis. 194:176-183. (Pubitemid 44087188)
37. Medzhitov R. 2001. Toll-like receptors and innate immunity. Nat. Rev. 1:135-145. (Pubitemid 33741967)
38. Kutuzova GD, Albrecht RM, Erickson CM, Qureshi N. 2001. Diphosphoryl lipid A from Rhodobacter sphaeroides blocks the binding and internalization of lipopolysaccharide in RAW 264.7 cells. J. Immunol. 167:482-489. (Pubitemid 32567815)
39. Skinner NA, MacIsaac CM, Hamilton JA, Visvanathan K. 2005. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens. Clin. Exp. Immunol. 141:270-278. (Pubitemid 41003351)
40. Webster NL, Kedzierska K, Azzam R, Paukovics G, Wilson J, Crowe SM, Jaworowski A. 2006. Phagocytosis stimulates mobilization and shedding of intracellular CD16A in human monocytes and macrophages: inhibition by HIV-1 infection. J. Leukoc. Biol. 79:294-302. (Pubitemid 44831161)
41. Tobian AA, Mehlotra RK, Malhotra I, Wamachi A, Mungai P, Koech D, Ouma J, Zimmerman P, King CL. 2000. Frequent umbilical cord-blood and maternal-blood infections with Plasmodium falciparum, P. malariae, and P. ovale in Kenya. J. Infect. Dis. 182:558-563. (Pubitemid 30651054)
42. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM. 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336:1201-1204. (Pubitemid 20382913)
43. Onguru D, Liang Y, Griffith Q, Nikolajczyk B, Mwinzi P, Ganley-Leal L. 2011. Human schistosomiasis is associated with endotoxemia and Toll-like receptor 2- and 4-bearing B cells. Am. J. Trop. Med. Hyg. 84:321-324.
44. Angelone DF, Wessels MR, Coughlin M, Suter EE, Valentini P, Kalish LA, Levy O. 2006. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr. Res. 60:205-209. (Pubitemid 44297594)
45. Berner R, Furll B, Stelter F, Drose J, Muller HP, Schutt C. 2002. Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis. Clin. Diagn. Lab. Immunol. 9:440-445. (Pubitemid 34226044)
46. Chow JM, Lin HY, Shen SC, Wu MS, Lin CW, Chiu WT, Lin CH, Chen YC. 2009. Zinc protoporphyrin inhibition of lipopolysaccharide-, lipoteichoic acid-, and peptidoglycan-induced nitric oxide production through stimulating iNOS protein ubiquitination. Toxicol. Appl. Pharmacol. 237:357-365.
47. Hochart H, Jenkins PV, Preston RJ, Smith OP, White B, O'Donnell J. 2008. Concentration-dependent roles for heparin in modifying lipopolysaccharide- induced activation of mononuclear cells in whole blood. Thromb. Haemost. 99:570-575. (Pubitemid 351549294)
48. Kato A, Ogasawara T, Homma T, Saito H, Matsumoto K. 2004. Lipopolysaccharide-binding protein critically regulates lipopolysaccharide- induced IFN-beta signaling pathway in human monocytes. J. Immunol. 172:6185-6194. (Pubitemid 38621224)
49. Levy O, Coughlin M, Cronstein BN, Roy RM, Desai A, Wessels MR. 2006. The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J. Immunol. 177:1956-1966. (Pubitemid 44092536)
50. Sadeghi K, Berger A, Langgartner M, Prusa AR, Hayde M, Herkner K, Pollak A, Spittler A, Forster-Waldl E. 2007. Immaturity of infection control in preterm and term newborns is associated with impaired Toll-like receptor signaling. J. Infect. Dis. 195:296-302. (Pubitemid 46080062)
51. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, Di Marco F, French L, Tschopp J. 1998. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273:12203-12209. (Pubitemid 28240584)
52. Doz E, Rose S, Nigou J, Gilleron M, Puzo G, Erard F, Ryffel B, Quesniaux VF. 2007. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J. Biol. Chem. 282:26014-26025. (Pubitemid 47443801)
53. Farhat K, Riekenberg S, Heine H, Debarry J, Lang R, Mages J, Buwitt-Beckmann U, Roschmann K, Jung G, Wiesmuller KH, Ulmer AJ. 2008. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J. Leukoc. Biol. 83:692-701. (Pubitemid 351966879)
54. Wang R, Stephens J, Lacy MJ. 2003. Characterization of monoclonal antibody HTA125 with specificity for human TLR4. Hybrid. Hybridomics 22:357-365. (Pubitemid 38037446)
55. Teghanemt A, Zhang D, Levis EN, Weiss JP, Gioannini TL. 2005. Molecular basis of reduced potency of underacylated endotoxins. J. Immunol. 175:4669-4676. (Pubitemid 41362008)
56. Carpenter S, O'Neill LA. 2009. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem. J. 422:1-10.
57. Kalis C, Kanzler B, Lembo A, Poltorak A, Galanos C, Freudenberg MA. 2003. Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in mice. Eur. J. Immunol. 33:798-805. (Pubitemid 36367683)
58. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, Miyake K, Takeda K, Akira S. 2000. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J. Immunol. 164:3476-3479. (Pubitemid 30169796)
59. De Creus A, Abe M, Lau AH, Hackstein H, Raimondi G, Thomson AW. 2005. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J. Immunol. 174:2037-2045. (Pubitemid 40223946)
60. Chelvarajan RL, Collins SM, Doubinskaia IE, Goes S, Van Willigen J, Flanagan D, De Villiers WJ, Bryson JS, Bondada S. 2004. Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens. J. Leukoc. Biol. 75:982-994. (Pubitemid 38720638)
61. Ando M, Shibuya A, Tsuchiya K, Akiba T, Nitta K. 2006. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int. 70:358-362. (Pubitemid 44086586)
62. Tsujimoto H, Ono S, Hiraki S, Majima T, Kawarabayashi N, Sugasawa H, Kinoshita M, Hiraide H, Mochizuki H. 2004. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock. J. Endotoxin Res. 10:229-237. (Pubitemid 39481012)
63. Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H. 2004. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 50:1457-1467. (Pubitemid 38608067)
64. Baumgarth N, Roederer M. 2000. A practical approach to multicolor flow cytometry for immunophenotyping. J. Immunol. Methods 243:77-97.
65. Drohan L, Harding JJ, Holm B, Cordoba-Tongson E, Dekker CL, Holmes T, Maecker H, Mellins ED. 2004. Selective developmental defects of cord blood antigen-presenting cell subsets. Hum. Immunol. 65:1356-1369. (Pubitemid 39535299)